BHVN
Biohaven Ltd.$9.60+0.01 (+0.05%)Prev Close$9.59·MCap$1.11B·P/E—·Vol986.7K·Yield—
▲
Buys (12M)
4
$30.64M
▼
Sells (12M)
5
$153.7K
◆
Net Activity
Net Buyer
$30.49M
●
Active Insiders
9
last 12 mo
Over the past 12 months, insider activity at Biohaven Ltd. (BHVN) has been dominated by buying, with 4 insider purchases totaling $30.64M and 5 insider sales totaling $153.7K. The most recent insider transaction was by Buten Matthew (Chief Financial Officer), who sold $25.8K worth of shares on Jan 5, 2026. Biohaven Ltd. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.11B.
BHVN Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | Buten Matthew | Chief Financial Officer | Sell | 2,594 | $9.93 | $25.8K | 0 |
| Jan 5, 2026 | Car Bruce | Chief Scientific Officer | Sell | 2,381 | $9.93 | $23.6K | 0 |
| Jan 5, 2026 | Clark George C. | VP, Chief Accounting Officer | Sell | 1,117 | $9.93 | $11.1K | 0 |
| Jan 5, 2026 | Coric Vlad | Chief Executive Officer | Sell | 7,430 | $9.93 | $73.8K | 0 |
| Jan 5, 2026 | Gentile Kimberly | SVP, Clinical Operations | Sell | 1,956 | $9.93 | $19.4K | 0 |
| Nov 17, 2025 | Clark George C. | VP, Chief Accounting Officer | Buy | 17,000 | $8.52 | $144.8K | 0 |
| Nov 13, 2025 | Bailey Gregory | Director | Buy | 400,000 | $7.50 | $3.00M | 0 |
| Nov 13, 2025 | CHILDS JOHN W | Director | Buy | 3,333,333 | $7.50 | $25.00M3.1% OS | 0 |
| Nov 13, 2025 | Coric Vlad | Chief Executive Officer | Buy | 333,333 | $7.50 | $2.50M | 0 |
| Mar 4, 2025 | CHILDS JOHN W | Director | Buy | 29,300 | $30.44 | $891.8K | 0 |
| Jan 5, 2025 | Buten Matthew | Chief Financial Officer | Sell | 2,561 | $38.64 | $99.0K | 0 |
| Jan 5, 2025 | Car Bruce | Chief Scientific Officer | Sell | 2,331 | $38.64 | $90.1K | 0 |
| Jan 5, 2025 | Clark George C. | VP, Chief Accounting Officer | Sell | 1,117 | $38.64 | $43.2K | 0 |
| Jan 5, 2025 | Coric Vlad | Chief Executive Officer | Sell | 6,805 | $38.64 | $262.9K | 0 |
| Jan 5, 2025 | Gentile Kimberly | SVP, Clinical Operations | Sell | 1,956 | $38.64 | $75.6K | 0 |
| Dec 30, 2024 | CHILDS JOHN W | Director | Buy | 29,000 | $35.94 | $1.04M | 0 |
| Oct 2, 2024 | CHILDS JOHN W | Director | Buy | 21,052 | $47.50 | $1000.0K | 0 |
| Sep 24, 2024 | Bailey Gregory | Director | Buy | 5,000 | $44.19 | $221.0K | 0 |
| Jul 18, 2024 | CHILDS JOHN W | Director | Buy | 28,400 | $35.67 | $1.01M | 0 |
| Jun 17, 2024 | Car Bruce | Chief Scientific Officer | Buy | 30,000 | $33.58 | $1.01M | 0 |
| May 30, 2024 | CHILDS JOHN W | Director | Buy | 28,000 | $35.58 | $996.2K | 0 |
| May 13, 2024 | Bailey Gregory | Director | Buy | 15,000 | $34.19 | $512.9K | 0 |
| May 13, 2024 | CHILDS JOHN W | Director | Buy | 28,500 | $35.17 | $1.00M | 0 |
| Apr 24, 2024 | Bailey Gregory | Director | Buy | 25,503 | $39.18 | $999.2K | 0 |
| Apr 22, 2024 | Bailey Gregory | Director | Buy | 48,780 | $41.00 | $2.00M | 0 |
| Apr 22, 2024 | CHILDS JOHN W | Director | Buy | 195,121 | $41.00 | $8.00M | 0 |
| Apr 22, 2024 | Coric Vlad | Chief Executive Officer | Buy | 121,951 | $41.00 | $5.00M | 0 |
| Dec 29, 2023 | Antonijevic Irina | Director | Sell | 11,000 | $41.79 | $459.7K | 0 |
| Oct 5, 2023 | Buten Matthew | Chief Financial Officer | Buy | 22,727 | $22.00 | $500.0K | 0 |
| Oct 5, 2023 | CHILDS JOHN W | Director | Buy | 454,545 | $22.00 | $10.00M | 0 |
| Oct 5, 2023 | Coric Vlad | Chief Executive Officer | Buy | 454,545 | $22.00 | $10.00M | 0 |
| Oct 4, 2023 | Bailey Gregory | Director | Buy | 17,817 | $22.57 | $402.1K | 0 |
| Aug 30, 2023 | CHILDS JOHN W | Director | Buy | 50,000 | $18.44 | $922.2K | 0 |
| Aug 4, 2023 | CHILDS JOHN W | Director | Buy | 100,000 | $19.78 | $1.98M | 0 |
| Oct 31, 2022 | Coric Vlad | Chief Executive Officer | Buy | 25,800 | $15.97 | $412.0K | 0 |
| Oct 28, 2022 | Coric Vlad | Chief Executive Officer | Buy | 141,930 | $14.84 | $2.11M | 0 |
| Oct 25, 2022 | Bailey Gregory | Director | Buy | 200,000 | $10.50 | $2.10M | 0 |
| Oct 25, 2022 | Buten Matthew | Chief Financial Officer | Buy | 142,857 | $10.50 | $1.50M | 0 |
| Oct 25, 2022 | CHILDS JOHN W | Director | Buy | 3,900,000 | $10.50 | $40.95M3.7% OS | 0 |
| Oct 25, 2022 | Coric Vlad | Chief Executive Officer | Buy | 853,380 | $10.50 | $8.96M0.8% OS | 0 |
| Oct 25, 2022 | GREGORY JULIA P | Director | Buy | 9,523 | $10.50 | $100.0K | 0 |
| Oct 5, 2022 | CHILDS JOHN W | Director | Buy | 274,141 | $8.98 | $2.46M | 0 |
| Oct 5, 2022 | Coric Vlad | Chief Executive Officer | Buy | 485,775 | $10.31 | $5.01M | 0 |
| Oct 3, 2022 | Buten Matthew | Chief Financial Officer | Sell | 11,042 | $7.50 | $82.8K | 0 |
| Oct 3, 2022 | Coric Vlad | Chief Executive Officer | Sell | 115,940 | $7.50 | $869.5K | 0 |
| Oct 3, 2022 | Gentile Kimberly | SVP, Clinical Operations | Sell | 37,492 | $7.00 | $262.4K | 0 |
| Oct 3, 2022 | GREGORY JULIA P | Director | Sell | 11,975 | $7.50 | $89.8K | 0 |
| Oct 3, 2022 | Heffernan Michael Thomas | Director | Sell | 5,507 | $7.50 | $41.3K | 0 |
| Oct 3, 2022 | HUGIN ROBERT J | Director | Sell | 3,263 | $7.50 | $24.5K | 0 |
| Oct 3, 2022 | Mehta Kishan | Director | Sell | 11,716 | $7.00 | $82.0K | 0 |
BHVN Insider Buying Activity
The following table shows recent insider purchases of Biohaven Ltd. (BHVN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | Clark George C. | VP, Chief Accounting Officer | Buy | 17,000 | $8.52 | $144.8K | 0 |
| Nov 13, 2025 | Bailey Gregory | Director | Buy | 400,000 | $7.50 | $3.00M | 0 |
| Nov 13, 2025 | CHILDS JOHN W | Director | Buy | 3,333,333 | $7.50 | $25.00M3.1% OS | 0 |
| Nov 13, 2025 | Coric Vlad | Chief Executive Officer | Buy | 333,333 | $7.50 | $2.50M | 0 |
| Mar 4, 2025 | CHILDS JOHN W | Director | Buy | 29,300 | $30.44 | $891.8K | 0 |
| Dec 30, 2024 | CHILDS JOHN W | Director | Buy | 29,000 | $35.94 | $1.04M | 0 |
| Oct 2, 2024 | CHILDS JOHN W | Director | Buy | 21,052 | $47.50 | $1000.0K | 0 |
| Sep 24, 2024 | Bailey Gregory | Director | Buy | 5,000 | $44.19 | $221.0K | 0 |
| Jul 18, 2024 | CHILDS JOHN W | Director | Buy | 28,400 | $35.67 | $1.01M | 0 |
| Jun 17, 2024 | Car Bruce | Chief Scientific Officer | Buy | 30,000 | $33.58 | $1.01M | 0 |
| May 30, 2024 | CHILDS JOHN W | Director | Buy | 28,000 | $35.58 | $996.2K | 0 |
| May 13, 2024 | Bailey Gregory | Director | Buy | 15,000 | $34.19 | $512.9K | 0 |
| May 13, 2024 | CHILDS JOHN W | Director | Buy | 28,500 | $35.17 | $1.00M | 0 |
| Apr 24, 2024 | Bailey Gregory | Director | Buy | 25,503 | $39.18 | $999.2K | 0 |
| Apr 22, 2024 | Bailey Gregory | Director | Buy | 48,780 | $41.00 | $2.00M | 0 |
| Apr 22, 2024 | CHILDS JOHN W | Director | Buy | 195,121 | $41.00 | $8.00M | 0 |
| Apr 22, 2024 | Coric Vlad | Chief Executive Officer | Buy | 121,951 | $41.00 | $5.00M | 0 |
| Oct 5, 2023 | Buten Matthew | Chief Financial Officer | Buy | 22,727 | $22.00 | $500.0K | 0 |
| Oct 5, 2023 | CHILDS JOHN W | Director | Buy | 454,545 | $22.00 | $10.00M | 0 |
| Oct 5, 2023 | Coric Vlad | Chief Executive Officer | Buy | 454,545 | $22.00 | $10.00M | 0 |
| Oct 4, 2023 | Bailey Gregory | Director | Buy | 17,817 | $22.57 | $402.1K | 0 |
| Aug 30, 2023 | CHILDS JOHN W | Director | Buy | 50,000 | $18.44 | $922.2K | 0 |
| Aug 4, 2023 | CHILDS JOHN W | Director | Buy | 100,000 | $19.78 | $1.98M | 0 |
| Oct 31, 2022 | Coric Vlad | Chief Executive Officer | Buy | 25,800 | $15.97 | $412.0K | 0 |
| Oct 28, 2022 | Coric Vlad | Chief Executive Officer | Buy | 141,930 | $14.84 | $2.11M | 0 |
| Oct 25, 2022 | Bailey Gregory | Director | Buy | 200,000 | $10.50 | $2.10M | 0 |
| Oct 25, 2022 | Buten Matthew | Chief Financial Officer | Buy | 142,857 | $10.50 | $1.50M | 0 |
| Oct 25, 2022 | CHILDS JOHN W | Director | Buy | 3,900,000 | $10.50 | $40.95M3.7% OS | 0 |
| Oct 25, 2022 | Coric Vlad | Chief Executive Officer | Buy | 853,380 | $10.50 | $8.96M0.8% OS | 0 |
| Oct 25, 2022 | GREGORY JULIA P | Director | Buy | 9,523 | $10.50 | $100.0K | 0 |
| Oct 5, 2022 | CHILDS JOHN W | Director | Buy | 274,141 | $8.98 | $2.46M | 0 |
| Oct 5, 2022 | Coric Vlad | Chief Executive Officer | Buy | 485,775 | $10.31 | $5.01M | 0 |
BHVN Insider Selling Activity
The following table shows recent insider sales of Biohaven Ltd. (BHVN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | Buten Matthew | Chief Financial Officer | Sell | 2,594 | $9.93 | $25.8K | 0 |
| Jan 5, 2026 | Car Bruce | Chief Scientific Officer | Sell | 2,381 | $9.93 | $23.6K | 0 |
| Jan 5, 2026 | Clark George C. | VP, Chief Accounting Officer | Sell | 1,117 | $9.93 | $11.1K | 0 |
| Jan 5, 2026 | Coric Vlad | Chief Executive Officer | Sell | 7,430 | $9.93 | $73.8K | 0 |
| Jan 5, 2026 | Gentile Kimberly | SVP, Clinical Operations | Sell | 1,956 | $9.93 | $19.4K | 0 |
| Jan 5, 2025 | Buten Matthew | Chief Financial Officer | Sell | 2,561 | $38.64 | $99.0K | 0 |
| Jan 5, 2025 | Car Bruce | Chief Scientific Officer | Sell | 2,331 | $38.64 | $90.1K | 0 |
| Jan 5, 2025 | Clark George C. | VP, Chief Accounting Officer | Sell | 1,117 | $38.64 | $43.2K | 0 |
| Jan 5, 2025 | Coric Vlad | Chief Executive Officer | Sell | 6,805 | $38.64 | $262.9K | 0 |
| Jan 5, 2025 | Gentile Kimberly | SVP, Clinical Operations | Sell | 1,956 | $38.64 | $75.6K | 0 |
| Dec 29, 2023 | Antonijevic Irina | Director | Sell | 11,000 | $41.79 | $459.7K | 0 |
| Oct 3, 2022 | Buten Matthew | Chief Financial Officer | Sell | 11,042 | $7.50 | $82.8K | 0 |
| Oct 3, 2022 | Coric Vlad | Chief Executive Officer | Sell | 115,940 | $7.50 | $869.5K | 0 |
| Oct 3, 2022 | Gentile Kimberly | SVP, Clinical Operations | Sell | 37,492 | $7.00 | $262.4K | 0 |
| Oct 3, 2022 | GREGORY JULIA P | Director | Sell | 11,975 | $7.50 | $89.8K | 0 |
| Oct 3, 2022 | Heffernan Michael Thomas | Director | Sell | 5,507 | $7.50 | $41.3K | 0 |
| Oct 3, 2022 | HUGIN ROBERT J | Director | Sell | 3,263 | $7.50 | $24.5K | 0 |
| Oct 3, 2022 | Mehta Kishan | Director | Sell | 11,716 | $7.00 | $82.0K | 0 |
BHVN Insiders
Similar Stocks to BHVN
VRTX
Vertex Pharmaceuticals Incorporated
$429.47+0.81%
$111.71B
REGN
Regeneron Pharmaceuticals, Inc.
$734.06-1.39%
$77.87B
ALNY
Alnylam Pharmaceuticals, Inc.
$303.44-1.64%
$41.24B
INSM
Insmed Incorporated
$135.11-0.64%
$30.79B
RVMD
Revolution Medicines, Inc.
$144.62+9.92%
$29.51B
UTHR
United Therapeutics Corporation
$566.69+0.03%
$25.13B
MRNA
Moderna, Inc.
$47.16-3.17%
$21.42B
RPRX
Royalty Pharma plc
$49.40-0.50%
$21.20B